Gilead pauses access to experimental COVID-19 drug due to 'overwhelming demand' squib

Gilead Sciences has temporarily stopped granting patients access to remdesivir, its experimental drug against the novel coronavirus that causes COVID-19, citing "overwhelming demand," STAT News reports.
Scroll for more
Continue reading on CNBC...
Tags: